medigraphic.com
ISSN 1561-3011 (Electronic)

2012, Number 2

<< Back Next >>

Rev Cubana Invest Bioméd 2012; 31 (2)

Short QT syndrome

Cruz CM

Language: Spanish
References: 38
Page: 145-156
PDF size: 112.00 Kb.


ABSTRACT

The short QT syndrome is an inherited channelopathy characterized by an abnormal shortening of the QT interval (QTI), an increased risk of developing atrial fibrillation and/or malignant ventricular arrhythmias, and the absence of structural heart disease. It is a heterogeneous disease and mutations have been identified in the genes encoding potassium and calcium channels. An increase in potassium net efflux or a decrease in calcium influx facilitate the heterogeneous shortening of ventricular repolarization. A marked shortening of the wavelength of the circuit is an additional arrhythmogenic factor. The clinical course ranges from asymptomatic forms to paroxysmal or permanent atrial fibrillation, syncope, ventricular arrhythmias and sudden death. The ECG shows QTI 220-360 ms, high and sharp T waves, prolongation of the final peak interval of the T wave, and QTI drive. It is a rare disease whose importance lies in the high risk of sudden death, which may sometimes be its debut. It may overlap Brugada syndrome and early repolarization. Diagnosis requires excluding secondary causes of QTI shortening. Failure to identify a mutation does not exclude it. Programmed electrical stimulation has a low diagnostic and prognostic value. Defibrillation is the therapy of choice for patients with aborted sudden death or ventricular arrhythmias with hemodynamic compromise. Quinidine is an alternative therapeutic option.


REFERENCES

  1. Gussak I, Brugada P, Brugada J, Wright RS, Kopecky SL, Chaitman BR, et al. Idiopathic short QT interval: a new clinical syndrome? Cardiology. 2000;94:99-102.

  2. Gussak I, Bjerregaard P. Short QT syndrome: 5 years of progress. J Electrocardiol. 2005;38:375-7.

  3. Algra A, Tijssen JGP, Roelandt JRTC, Pool J, Lubsen J. QT interval variables from 24-Hour electrocardiography and the 2-year risk of sudden death. Br Heart J. 1993;70:43-8.

  4. Viskin S, Zeltsner D, Ish-Shalom M, Katz A, Glikson M, Justo D, et al. Is idiopathic ventricular fibrillation a short QT syndrome? Comparison of QT intervals of patients with idiopathic ventricular fibrillation and healthy controls. Heart Rhythm. 2004;1:587-91.

  5. Fei L, Camm AJ. Shortening of the QT interval immediately preceding the onset of idiopathic spontaneous ventricular tachycardia. Am Heart J. 1995;130:915-7.

  6. Kontny F, Dale J. Self-terminating idiopathic ventricular fibrillation presenting as syncope: a 40-year follow-up report. J Intern Med. 1990;227:211-3.

  7. Campbell TJ. Characteristics of cardiac action potentials in marsupials. J Comp Physiol. 1989;158:759-62.

  8. Anttonen O, Junttila MJ, Rissanen H, Reunanen A, Viitasalo M, Hiukuri HV, et al. Prevalence and prognostic significance of short QT interval in a middle-aged Finnish population. Circulation. 2007;116:714-20.

  9. Gallagher MM, Magliano G, Yap YG, Padula M, Morgia V, Postorino C, et al. Distribution and prognostic significance of QT intervals in the lowest half centile in 12,012 apparently healthy persons. Am J Cardiol. 2006;98:933-5.

  10. Brugada R, Hong K, Dumaine R, Cordeiro JM, Gaita F, Borggrefe M, et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation. 2004;109:30-5.

  11. Bellocq C, Van Ginnneken CA, Bezzina CR, Alders M, Escande D, Mannens MM, et al. Mutation in the KCNQ1 gene leading to the short QT- interval syndrome. Circulation. 2004;109:2394-7.

  12. Hong K, Piper DR, Diaz-Valdecantos, Brugada J, Oliva A, Burashnikov E, et al. De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc Res. 2005;68:433-40.

  13. Priori SG, Pandit SV, Rivolta I, Berenfeld O, Ronchetti E, Dhamoon A, et al. A novel form of short QT syndrome (SQT3) is cause by mutation in the HCNJ2 gene. Circ Res. 2005;96:800-7.

  14. Antzelevitch C, Pollevick GD, Cordeiro JM, Casis O, Sanguinetti MC, Aizawa Y, et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation. 2007;115:442-9.

  15. Anttonen O, Vaananen H, Junttila J, Huikuri HV, Viitasalo M. Electrocardiographic transmural dispersion of repolarization in patients with inherited short QT syndrome. Ann Noninvasive Electrocardiol. 2008;13:295-300.

  16. Patel C, Antzelevitch C. Cellular basis for arrhythmogenesis in an experimental model of the SQT1 form of the short QT syndrome. Heart Rhythm. 2008;5:585-90.

  17. Gupta P, Patel C, Patel H, Narayanaswamy S, Malhotra B, Green JT, et al. Tp-e/QT ratio as an index of arrhythmogenesis. J Electrocardiol. 2008;41:567-74.

  18. Anttonen O, Junttila MJ, Maury P, Schimpf R, Wolpert C, Borggrefe M, et al. Differences in twelve-lead electrocardiogram between symptomatic and asymptomatic subjects with short QT interval. Heart Rhythm. 2009;6:26771.

  19. Schimpf R, Bauersfeld U, Gaita F, Wolpert C. Short QT syndrome: successful prevention of sudden cardiac death in an adolescent by implantable cardioverter-defibrillator treatment for primary prophylaxis. Heart Rhythm. 2005;2:4167.

  20. Patel Ch, Yan GX, Antzelevitch C. Short QT Syndrome: From bench to bedside. Circ Arrhythm Electrophysiol. 2010;3 401-8.

  21. Schimpf R, Antzelevitch C, Haghi D, Giustetto C, Pizzuti A, Gaita F, et al. Electromechanical coupling in patients with the short QT syndrome: further insights into the mechanoelectrical hypothesis of the U wave. Heart Rhythm. 2008;5:2415.

  22. Sugishita Y, Iida K, O'Rourke MF, Kelly R, Avolio A, Butcher D, et al. Echocardiographic and electrocardiographic study of the normal kangaroo heart. Aust N Z J Med. 1990;20:1605.

  23. Giata F, Giustetto C, Bianchi F, Wolpert C, Schimpf R, Riccardi R, et al. Short QT syndrome: a familial cause of sudden death. Circulation. 2003;108:965-70.

  24. Wolpert C, Schimpf R, Veltmann C, Giustetto C, Gaita F, Borggrefe M. Clinical caracteristics and treatment of short QT syndrome. Expert Rev Ther. 2005;4:611-7.

  25. Giustetto C, Di Monte F, Wolpert C, Borggrefe M, Schimpf, Sbragia P, et al. Short QT syndrome: clinical findings and diagnostic-therapeutic implications. Eur Heart J. 2006;27:24407.

  26. Wolpert C, Schimpf R, Giustetto C, Antzelevitch C, Cordeiro JM, Dumaine R, et al. Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG. J Cardiovasc Electrophysiol. 2005;16:548.

  27. Watanabe H, Makiyama T, Koyama T, Kannankeril PJ, Seto S, Okamura K, et al. High prevalence of early repolarization in short QT syndrome. Heart Rhythm. 2010;7:64752.

  28. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart J. 1920;7:35370.

  29. Kobza R, Roos M, Niggli B, Abacherli R, Lupi GA, Frey F, et al. Prevalence of long and short QT in a young population of 41,767 predominantly male Swiss conscripts. Heart Rhythm. 2009;6:6527.

  30. Rautaharju PM, Zhou SH, Wong S, Calhoun HP, Berenson GS, Prineas R, et al. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol. 1992;8:6905.

  31. Gollob MH, Redpath CJ, Roberts JD. The short QT syndrome proposed diagnostic criteria. J Am Coll Cardiol. 2011;57:802-12.

  32. Schulze-Bahr E, Breithardt G. Short QT interval and short QT syndromes. J Cardiovasc Electrophysiol. 2005;16:397-8.

  33. Bjerregaard P, Gussak I. Short QT syndrome: mechanisms, diagnosis and treatment. Nat Clin Pract Cardiovasc Med. 2005;2:847.

  34. Schimpf R, Wolpert C, Bianchi F, Giustetto C, Gaita F, Bauersfeld U, et al. Congenital short QT syndrome and implantable cardio- verter defibrillator treatment: inherent risk for inappropriate shock delivery. J Cardiovasc Electrophysiol. 2003;14:12737.

  35. Gaita F, Giustetto C, Bianchi F, Schimpf R, Haissaguerre M, Calo L, et al. Short QT syndrome: pharmacological treatment. J Am Coll Cardiol. 2004;43:14949.

  36. Schimpf R, Antzelevitch C, Hsu LF, Schickel S, Pollevick GD, Cordeiro JM, et al. The QT-intervalin patients with a Brugada syndrome: is a shortening of the QT-time an existing and relevant ECG-pattern. Heart Rhythm. 2007;4:S188.

  37. Lu LX, Zhou W, Zhang X, Cao Q, Yu K, Zhu C. Short QT syndrome: a case report and review of literature. Resuscitation. 2006;71:11521.

  38. Hong K, Bjerregaard P, Gussak I, Brugada. Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. J Cardiovasc Electrophysiol. 2005;16:3946.




2020     |     www.medigraphic.com